F10 and atrial fibrillation: The relevance of these findings is that there is potentially a new anticoagulant strategy to reduce major bleeding compared to standard-of-care (FXa inhibitors), and whilst our study specifically analyzed patients with an indication for anticoagulation for thromboprophylaxis of AF, other patients with indications for anticoagulation may also benefit from such a strategy to reduce major bleeding.